Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) (HENGRUI) balance sheet

SHH · Healthcare · Drug Manufacturers - Specialty & Generic · 20,602 employees · CEO Sun Piaoyang

Price: CN¥48.97 +1.05%
Market cap: CN¥312B
Enterprise value: CN¥269B
Last report: Q3 '26 filed 2026-09-30
Next report: 2027-04-19 EPS est. CN¥0.32

At the end of Q3 '26 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (A shares) (HENGRUI) held CN¥43.6B in cash and short-term investments against CN¥422M of debt incl. leases. Total assets CN¥76.7B, total liabilities CN¥9.38B, shareholders' equity CN¥66.8B.

Balance sheet

Balance sheet	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26	Q3 '26
Assets
Cash & equivalents	CN¥20.7B	CN¥21.3B	CN¥22.3B	CN¥22.1B	CN¥24.8B	CN¥24.1B	CN¥36.1B	CN¥40.4B	CN¥41B	CN¥40.5B	CN¥38.7B	CN¥43.4B
Short-term investments	CN¥99M	CN¥466M	CN¥973M	CN¥774M	CN¥273M	CN¥110M	CN¥109M	CN¥111M	CN¥114M	CN¥109M	CN¥107M	CN¥113M
Receivables	CN¥6.13B	CN¥7.84B	CN¥7.32B	CN¥7.36B	CN¥6.23B	CN¥7.34B	CN¥6.08B	CN¥6.26B	CN¥6.32B	CN¥6.51B	CN¥6.62B	CN¥6.46B
Inventory	CN¥2.31B	CN¥2.27B	CN¥2.25B	CN¥2.53B	CN¥2.42B	CN¥2.4B	CN¥2.58B	CN¥2.74B	CN¥2.88B	CN¥2.89B	CN¥2.99B	CN¥3.04B
Other current assets	CN¥1.77B	CN¥402M	CN¥2.07B	CN¥433M	CN¥435M	CN¥458M	CN¥397M	CN¥486M	CN¥3	CN¥505M	CN¥0	CN¥373M
Current assets	CN¥31.3B	CN¥33.7B	CN¥34.8B	CN¥34.5B	CN¥35.3B	CN¥36B	CN¥46.8B	CN¥51.4B	CN¥51.5B	CN¥52B	CN¥49.6B	CN¥54.6B
Property, plant & equipment (net)	CN¥6.63B	CN¥6.57B	CN¥6.83B	CN¥6.69B	CN¥6.93B	CN¥7.08B	CN¥7.23B	CN¥7.43B	CN¥8.37B	CN¥8.13B	CN¥8.99B	CN¥8.77B
Long-term investments	CN¥1.35B	CN¥803M	CN¥1.5B	CN¥1.47B	CN¥1.46B	CN¥1.6B	CN¥1.81B	CN¥1.78B	CN¥2.03B	CN¥2.13B	CN¥3.12B	CN¥3.01B
Intangible assets	CN¥3.38B	CN¥3.68B	CN¥4.18B	CN¥4.61B	CN¥5.03B	CN¥5.32B	CN¥5.77B	CN¥6.27B	CN¥6.83B	CN¥7.42B	CN¥7.96B	CN¥8.72B
Deferred tax assets	CN¥321M	CN¥366M	CN¥404M	CN¥413M	CN¥377M	CN¥415M	CN¥410M	CN¥498M	CN¥781M	CN¥772M	CN¥788M	CN¥810M
Other non-current assets	CN¥818M	CN¥1.2B	CN¥498M	CN¥703M	CN¥1.03B	CN¥905M	CN¥910M	CN¥939M	CN¥365M	CN¥796M	CN¥307M	CN¥864M
Non-current assets	CN¥12.5B	CN¥12.6B	CN¥13.4B	CN¥13.9B	CN¥14.8B	CN¥15.3B	CN¥16.1B	CN¥16.9B	CN¥18.4B	CN¥19.2B	CN¥21.2B	CN¥22.2B
Total assets	CN¥43.8B	CN¥46.3B	CN¥48.2B	CN¥48.3B	CN¥50.1B	CN¥51.3B	CN¥62.9B	CN¥68.3B	CN¥69.9B	CN¥71.3B	CN¥70.8B	CN¥76.7B
Liabilities
Accounts payable	CN¥1.33B	CN¥1.46B	CN¥1.44B	CN¥1.54B	CN¥1.97B	CN¥2B	CN¥2.2B	CN¥2.22B	CN¥2.27B	CN¥2.33B	CN¥2.03B	CN¥2.02B
Accrued expenses	CN¥140M	CN¥658K	CN¥122M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥5.43M	CN¥3.82M	CN¥1.63M	CN¥4.15M	CN¥3.67M
Short-term debt	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥46M	CN¥506M	CN¥31M	CN¥895M	CN¥30.4M	CN¥685M	CN¥393M
Taxes payable	CN¥219M	CN¥249M	CN¥112M	CN¥356M	CN¥427M	CN¥439M	CN¥428M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0
Deferred revenue	CN¥198M	CN¥1.45B	CN¥1.23B	CN¥0	CN¥160M	CN¥163M	CN¥161M	CN¥3.97B	CN¥1.91B	CN¥1.45B	CN¥949M	CN¥2.93B
Other current liabilities	CN¥882M	CN¥742M	CN¥1.91B	CN¥1.93B	CN¥204M	CN¥166M	-CN¥296M	CN¥1.1B	CN¥655M	CN¥1.05B	CN¥489M	CN¥1.06B
Current liabilities	CN¥2.55B	CN¥3.7B	CN¥4.81B	CN¥3.83B	CN¥3.63B	CN¥3.36B	CN¥3.47B	CN¥7.85B	CN¥6.37B	CN¥5.64B	CN¥4.25B	CN¥6.9B
Lease obligations (non-current)	CN¥75.2M	CN¥78.4M	CN¥58.3M	CN¥51.3M	CN¥69M	CN¥62.7M	CN¥45.5M	CN¥51.4M	CN¥43.3M	CN¥37.1M	CN¥38.2M	CN¥29M
Deferred revenue (non-current)	CN¥39M	CN¥39M	CN¥42.6M	CN¥42.6M	CN¥226M	CN¥216M	CN¥225M	CN¥258M	CN¥1.16B	CN¥384M	CN¥440M	CN¥482M
Deferred tax liabilities	CN¥83.6M	CN¥85.2M	CN¥85.1M	CN¥83.2M	CN¥117M	CN¥101M	CN¥128M	CN¥134M	CN¥117M	CN¥172M	CN¥275M	CN¥264M
Other non-current liabilities	CN¥0	CN¥0	-CN¥42.6M	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥917M	CN¥783M	CN¥1.71B
Non-current liabilities	CN¥198M	CN¥203M	CN¥143M	CN¥177M	CN¥412M	CN¥380M	CN¥399M	CN¥443M	CN¥1.7B	CN¥1.51B	CN¥1.54B	CN¥2.49B
Total liabilities	CN¥2.75B	CN¥3.9B	CN¥4.95B	CN¥4.01B	CN¥4.05B	CN¥3.74B	CN¥3.86B	CN¥8.3B	CN¥8.07B	CN¥7.15B	CN¥5.78B	CN¥9.38B
Equity
Common stock & paid-in capital	CN¥6.38B	CN¥6.38B	CN¥6.38B	CN¥6.38B	CN¥6.38B	CN¥6.38B	CN¥6.64B	CN¥6.64B	CN¥6.64B	CN¥6.64B	CN¥6.64B	CN¥6.64B
Retained earnings	CN¥28.8B	CN¥30.2B	CN¥31B	CN¥32.1B	CN¥33.9B	CN¥35.7B	CN¥37B	CN¥38.3B	CN¥40.2B	CN¥42.5B	CN¥43.3B	CN¥45.8B
Accumulated other comprehensive income	CN¥3.39B	CN¥6.42B	CN¥3.5B	CN¥6.53B	CN¥3.53B	CN¥6.17B	CN¥3.6B	CN¥16.3B	CN¥3.78B	CN¥16.3B	CN¥3.76B	CN¥16.5B
Shareholders' equity	CN¥40.5B	CN¥41.9B	CN¥42.6B	CN¥43.8B	CN¥45.5B	CN¥47B	CN¥58.5B	CN¥59.5B	CN¥61.3B	CN¥63.6B	CN¥64.5B	CN¥66.8B
Debt
Total debt (incl. leases)	CN¥75.2M	CN¥78.4M	CN¥488M	CN¥51.3M	CN¥69M	CN¥62.7M	CN¥551M	CN¥82.4M	CN¥938M	CN¥67.5M	CN¥724M	CN¥422M
Net debt (debt - cash)	-CN¥20.7B	-CN¥21.2B	-CN¥21.8B	-CN¥22.1B	-CN¥24.7B	-CN¥24B	-CN¥36.1B	-CN¥40.3B	-CN¥40B	-CN¥40.5B	-CN¥38B	-CN¥43B

Balance sheet	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Assets
Cash & equivalents	CN¥4.91B	CN¥4.27B	CN¥3.89B	CN¥5.04B	CN¥10.8B	CN¥13.6B	CN¥15.1B	CN¥20.7B	CN¥24.8B	CN¥41B
Short-term investments	CN¥0	CN¥0	CN¥0	CN¥8.52B	CN¥5.63B	CN¥5.09B	CN¥2.76B	CN¥99M	CN¥273M	CN¥114M
Receivables	CN¥3.45B	CN¥4.53B	CN¥4.43B	CN¥5.43B	CN¥8.18B	CN¥6.88B	CN¥8.34B	CN¥6.13B	CN¥6.23B	CN¥6.32B
Inventory	CN¥637M	CN¥790M	CN¥1.03B	CN¥1.61B	CN¥1.78B	CN¥2.4B	CN¥2.45B	CN¥2.31B	CN¥2.42B	CN¥2.88B
Other current assets	CN¥1.59B	CN¥4.64B	CN¥5.52B	CN¥1.62B	CN¥1.25B	CN¥1.75B	CN¥1.76B	CN¥1.77B	CN¥435M	CN¥3
Current assets	CN¥11.4B	CN¥14.5B	CN¥18.1B	CN¥22.3B	CN¥28.1B	CN¥30.2B	CN¥30.9B	CN¥31.3B	CN¥35.3B	CN¥51.5B
Property, plant & equipment (net)	CN¥2.47B	CN¥3.08B	CN¥3.69B	CN¥4.07B	CN¥4.59B	CN¥6.28B	CN¥6.68B	CN¥6.63B	CN¥6.93B	CN¥8.37B
Long-term investments	CN¥81M	CN¥123M	CN¥0	-CN¥7.92B	-CN¥4.13B	-CN¥4.09B	-CN¥1.25B	CN¥1.35B	CN¥1.46B	CN¥2.03B
Intangible assets	CN¥285M	CN¥279M	CN¥273M	CN¥350M	CN¥341M	CN¥702M	CN¥2.2B	CN¥3.38B	CN¥5.03B	CN¥6.83B
Deferred tax assets	CN¥92.5M	CN¥89.5M	CN¥112M	CN¥66.1M	CN¥53M	CN¥141M	CN¥223M	CN¥321M	CN¥377M	CN¥781M
Other non-current assets	CN¥4.63M	-CN¥11K	CN¥221M	CN¥8.67B	CN¥5.83B	CN¥6.05B	CN¥3.57B	CN¥818M	CN¥1.03B	CN¥365M
Non-current assets	CN¥2.94B	CN¥3.57B	CN¥4.29B	CN¥5.25B	CN¥6.68B	CN¥9.08B	CN¥11.4B	CN¥12.5B	CN¥14.8B	CN¥18.4B
Total assets	CN¥14.3B	CN¥18B	CN¥22.4B	CN¥27.6B	CN¥34.7B	CN¥39.3B	CN¥42.4B	CN¥43.8B	CN¥50.1B	CN¥69.9B
Liabilities
Accounts payable	CN¥755M	CN¥734M	CN¥1.4B	CN¥1.29B	CN¥1.33B	CN¥2.25B	CN¥1.77B	CN¥1.33B	CN¥1.97B	CN¥2.27B
Accrued expenses	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥97.6M	CN¥140M	CN¥0	CN¥3.82M
Short-term debt	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥1.26B	CN¥0	CN¥600M	CN¥895M
Taxes payable	CN¥307M	CN¥508M	CN¥132M	CN¥225M	CN¥176M	CN¥166M	CN¥119M	CN¥219M	CN¥427M	CN¥0
Deferred revenue	CN¥152M	CN¥211M	CN¥223M	CN¥221M	CN¥358M	CN¥220M	CN¥187M	CN¥198M	CN¥160M	CN¥1.91B
Other current liabilities	CN¥458M	CN¥211M	CN¥223M	CN¥963M	CN¥366M	CN¥235M	-CN¥86.2M	CN¥882M	-CN¥396M	CN¥655M
Current liabilities	CN¥1.36B	CN¥2.05B	CN¥2.49B	CN¥2.47B	CN¥3.77B	CN¥3.4B	CN¥3.64B	CN¥2.55B	CN¥3.63B	CN¥6.37B
Lease obligations (non-current)	CN¥0	CN¥0	CN¥0	CN¥0	CN¥0	CN¥152M	CN¥98.9M	CN¥75.2M	CN¥69M	CN¥43.3M
Deferred revenue (non-current)	CN¥90.8M	CN¥45.8M	CN¥69.9M	CN¥122M	CN¥141M	CN¥117M	CN¥119M	CN¥39M	CN¥226M	CN¥1.16B
Deferred tax liabilities	CN¥0	CN¥0	CN¥23M	CN¥24.1M	CN¥29.8M	CN¥24.8M	CN¥84.3M	CN¥83.6M	CN¥117M	CN¥117M
Other non-current liabilities	CN¥0	CN¥0	-CN¥23M	CN¥0	CN¥0	CN¥0	-CN¥16.1M	CN¥0	CN¥0	CN¥0
Non-current liabilities	CN¥90.8M	CN¥45.8M	CN¥69.9M	CN¥146M	CN¥171M	CN¥293M	CN¥303M	CN¥198M	CN¥412M	CN¥1.7B
Total liabilities	CN¥1.46B	CN¥2.1B	CN¥2.56B	CN¥2.62B	CN¥3.94B	CN¥3.69B	CN¥3.94B	CN¥2.75B	CN¥4.05B	CN¥8.07B
Equity
Common stock & paid-in capital	CN¥2.35B	CN¥2.83B	CN¥3.69B	CN¥4.42B	CN¥5.33B	CN¥6.4B	CN¥6.38B	CN¥6.38B	CN¥6.38B	CN¥6.64B
Retained earnings	CN¥8.4B	CN¥10.5B	CN¥13.1B	CN¥16.5B	CN¥20.8B	CN¥22.9B	CN¥25.5B	CN¥28.8B	CN¥33.9B	CN¥40.2B
Accumulated other comprehensive income	CN¥1.26B	CN¥1.11B	CN¥1.82B	CN¥2.48B	CN¥1.79B	CN¥3.03B	CN¥2.94B	CN¥19.3M	CN¥17M	CN¥3.78B
Shareholders' equity	CN¥12.4B	CN¥15.4B	CN¥19.7B	CN¥24.8B	CN¥30.5B	CN¥35B	CN¥37.8B	CN¥40.5B	CN¥45.5B	CN¥61.3B
Debt
Total debt (incl. leases)	CN¥43.4M	CN¥528M	CN¥655M	CN¥420M	CN¥1.6B	CN¥152M	CN¥1.36B	CN¥75.2M	CN¥69M	CN¥938M
Net debt (debt - cash)	-CN¥4.87B	-CN¥3.74B	-CN¥3.23B	-CN¥4.62B	-CN¥9.2B	-CN¥13.5B	-CN¥13.8B	-CN¥20.7B	-CN¥24.7B	-CN¥40B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in CNY.

Cash, investments and debt

quarter ends

The other statements

Income statementRevenue, costs, operating income, net income and EPSOpen Cash flowOperating cash flow, capex, free cash flow, buybacks and dividendsOpen

Sources

Statements, segment revenue, metrics and estimates: Financial Modeling Prep.

Data as of 2026-11-02